These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7791118)

  • 1. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
    Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
    Pabreza LA; Dhawan S; Kellar KJ
    Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
    Gopalakrishnan M; Molinari EJ; Sullivan JP
    Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
    Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties.
    Lin NH; Gunn DE; Ryther KB; Garvey DS; Donnelly-Roberts DL; Decker MW; Brioni JD; Buckley MJ; Rodrigues AD; Marsh KG; Anderson DJ; Buccafusco JJ; Prendergast MA; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1997 Jan; 40(3):385-90. PubMed ID: 9022806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U; Nordberg A
    Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
    Flores CM; Rogers SW; Pabreza LA; Wolfe BB; Kellar KJ
    Mol Pharmacol; 1992 Jan; 41(1):31-7. PubMed ID: 1732720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]cytisine binding to human brain membrane preparations.
    Hall M; Zerbe L; Leonard S; Freedman R
    Brain Res; 1993 Jan; 600(1):127-33. PubMed ID: 8422580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine.
    Happe HK; Peters JL; Bergman DA; Murrin LC
    Neuroscience; 1994 Oct; 62(3):929-44. PubMed ID: 7870314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    Brioni JD; O'Neill AB; Kim DJ; Buckley MJ; Decker MW; Arneric SP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):353-61. PubMed ID: 7965735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies.
    Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B
    J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
    Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.